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Abstract
A response to Toplak et al: Does replication groups scoring reduce false positive rate in SNP interaction discovery? BMC 
Genomics 2010, 11:58.
Background: The genomewide evaluation of genetic epistasis is a computationally demanding task, and a current 
challenge in Genetics. HFCC (Hypothesis-Free Clinical Cloning) is one of the methods that have been suggested for 
genomewide epistasis analysis. In order to perform an exhaustive search of epistasis, HFCC has implemented several 
tools and data filters, such as the use of multiple replication groups, and direction of effect and control filters. A recent 
article has claimed that the use of multiple replication groups (as implemented in HFCC) does not reduce the false 
positive rate, and we hereby try to clarify these issues.
Results/Discussion: HFCC uses, as an analysis strategy, the possibility of replicating findings in multiple replication 
groups, in order to select a liberal subset of preliminary results that are above a statistical criterion and consistent in 
direction of effect. We show that the use of replication groups and the direction filter reduces the false positive rate of a 
study, although at the expense of lowering the overall power of the study. A post-hoc analysis of these selected signals 
in the combined sample could then be performed to select the most promising results.
Conclusion: Replication of results in independent samples is generally used in scientific studies to establish credibility 
in a finding. Nonetheless, the combined analysis of several datasets is known to be a preferable and more powerful 
strategy for the selection of top signals. HFCC is a flexible and complete analysis tool, and one of its analysis options 
combines these two strategies: A preliminary multiple replication group analysis to eliminate inconsistent false positive 
results, and a post-hoc combined-group analysis to select the top signals.
Background
Epistasis, the interaction among genetic loci, is a frequent
phenomenon in nature [1]. However, the detection of epi-
static effects in observational data has not been an easy
task because of the lack of appropriate samples and meth-
odologies [2,3]. Thanks to the recent collection of large
genetic datasets, we are now at a position where the study
of epistasis in humans is becoming possible. Nonetheless,
the genomewide evaluation of genetic epistasis is a com-
putationally and statistically demanding task, due to the
large number of possible combinations of loci that can be
formed. For example, for a genomewide analysis with
100,000 SNPs, there are 5 × 109 two-locus combinations,
and 1.7 × 1014 three-locus combinations. For 1 million
SNPs, there are 5 × 1011 two-locus and 1.7 × 1017 three-
locus combinations.
The exhaustive search for epistasis across this large
data space is a challenge for today's genehunters. In this
context, a variety of software has been released to tackle
this issue ([4] for review). HFCC (Hypothesis-Free Clini-
cal Cloning) [4] is one of these tools that have made pos-
sible genomewide epistasis analysis. This software uses
case-control samples to test for single-locus or multi-
locus genetic association. Multi-locus combinations that
are significantly associated with a trait are then subjected
to a variety of post-hoc tests to determine the degree of
non-additivity of the marker combination, that is, to sep-
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arate additive multi-marker combinations from more epi-
static interactions. Those genetic effects that are due to
epistatic interactions are one of the priorities in our anal-
ysis, because they complement those effects detectable by
single-locus analysis.
Because HFCC performs an exhaustive search of the
entire data space, several optional tools have been imple-
mented to overcome this multiple testing problem, such
as multiple replication groups, the direction filter, the
control filter, the tracking filter, etc. For example, the
case-control sample can be simultaneously analyzed in
replication groups, to select only significant results in
each group. There is also a complementary direction fil-
ter, which selects only those results which are consistent
across groups, that is, they are significant and with the
same direction of effect in each group.
A recent article by Toplak et al. [5] has been inspired by
the following statement in HFCC's article [[4], page 3]: "...
a multi-group analysis strategy ... allows the replication of
consistent results, and it also aids the elimination of false
positive results, a very attractive quality for genome-wide
analysis of large number of genetic markers." These
authors have interpreted the above statement as claiming
that using replication groups, by itself, reduces "the false
positive rate" [[5], page 2], and can therefore "... improve
... any type of feature ranking and selection procedure ..."
[[5], page 1].
Our approach to detecting multi-locus effects uses a
two-stage analysis strategy. In a first step, a large subset of
preliminary results that are associated with the disease
are selected. Then, this liberal subset of results is sub-
jected to a post-hoc analysis to select the most promising
results [[4], page 7]. Using replication groups is only one
of the possible analysis strategies of HFCC, aiming to
reduce the number of selected signals, that is, it elimi-
nates a larger amount of the tail of the distribution of the
results, which are mostly false positives, together with
some true effects that are undistinguishable from unasso-
ciated variants [10].
Our original statement claims that using multiple repli-
cation groups should reduce the number of signals
selected with a liberal statistical threshold (mostly false
positives), but does not claim to use this strategy to select
the top results of the study. Indeed, to select the top find-
ings, we analyze the combined sample [[4], page 6],
which, as we state repeatedly across our article [[4], pages
2,3,4], is known to be the most powerful analysis strategy
[6,7].
Therefore it seems Toplak et al. interpreted our article
incorrectly, and applied this misinterpretation to test
their own hypothesis (replication groups aids prioritiza-
tion of signals), which was finally rejected by their simu-
lations. In their paper, these authors provide evidence
that the analysis of a combined sample is less prone to
false positives than the separate analysis of replication
samples. However, it is not clear from their article
whether they have selected signals consistent in strength
and direction, as suggested in our paper and in the guide-
lines for replication of association results [8], what may
compromise to some extent their results. In this study, we
have carried out HFCC analysis of several simulated data-
sets to evaluate the power and Type I error rate of the
combined-group and replication-groups analysis strate-
gies.
Methods
We simulated several case-control datasets using a freely
available software, genomeSIMLA [9]. Each dataset con-
sists of 3000 cases and 3000 controls genotyped for 20
SNPs, with minor allele frequencies between 0.1 and 0.5.
Different effect sizes were simulated, and each experi-
mental dataset was simulated 100 times, so that we could
estimate the power and Type I error rate under the
defined parameters. The first experiment was a null sim-
ulation, where all 20 snps were simulated under the null
hypothesis of no association between the SNPs and case
status. Next, we performed 3 experiments, each with
3000 cases and 3000 controls, 18 null SNPs, and one pair
of SNPs in epistatic association with case-status under
different effect sizes. The SNP pair was designed to have
a MAF = 0.3 for each SNP, having a larger penetrance
(.08) for only one genotype, the double-homozygote
(AAbb). A background penetrance of 0.05 (for all other
genotypes) versus the AAbb penetrance of 0.08 resulted
in a mean Odds-Ratio (OR) of 1.67 (Range = 1.34-2.25).
Decreasing the background penetrance to 0.04, resulted
in a mean OR of 2.10 (Range = 1.64-2.75). Finally, a back-
ground penetrance of 0.03 resulted in a mean OR of 2.85
(Range = 1.94-3.87).
In addition to these experiments, a mixed simulation
was carried out, in wich 3 different case-control samples
(ie, replication groups) were simulated, each with 1000
cases, 1000 controls, and 20 SNPs. Two replication
groups were simulated under the null hypothesis of no
association. A third replication group was simulated with
18 null SNPs, and a pair of SNPs in epistatic association
with background penetrance of 0.03 and AAbb pene-
trance of 0.08. These 3 replication groups were then
merged for a combined group analysis with an average
O R  o f  1 . 5 7 .  T h i s  e x p e r i m e n t  s i m u l a t e s  a n  s c e n a r i o  t o
search for consistent association results, where one case-
control sample shows an association which could be real
or could be due to sampling or genotyping artifacts, and
two other samples which do not exhibit this association.
Results
We analyzed each simulated dataset with the HFCC soft-
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with a significance level of 10-3, and a three-replication-
group analysis, with a significance level of 10-1 for each
group. This second strategy was applied with and without
the direction filter (consistency of direction of effect
across groups). HFCC was employed to test for associa-
tion between all two-locus SNP combinations and case-
status (20 SNPs produce 190 two-locus combinations).
For each bi-SNP combination, nine simple genetic mod-
els were tested, where each test compares the frequency
of one of the nine possible two-locus genotypes (AABB,
AABb, AAbb, AaBB, AaBb, Aabb, aaBB, aaBb, and aabb)
against the frequency of the remaining genotype classes.
The null simulations resulted in a Type I error rate of
0.00080 for the combined analysis, and 0.00086 for the 3-
group analysis. The observed type I error rate is a bit con-
servative compared to the theoretical rate (0.001), which
is probably due to the fact that some of the genetic model
tests are correlated. In any case, both analysis strategies
are similar and conservative. Most importantly, when the
direction filter is applied, the Type I error rate drops to
0.0002, much lower than for the two previous analyses,
proving that the replication group analysis, when the
direction filter is applied, reduces the false positive rate.
We then analyzed three datasets simulated under three
different effect sizes (Average OR of 1.67, 2.10, and 2.85).
Table 1 summarizes these results, where we find that the
combined analysis is, as expected and suggested in our
original paper [4], always more powerful than the 3-
group analyses. Nonetheless, and regarding Toplak et al.'s
main claim [5], the false positive rate decreases when we
use the 3-group strategy, and more so when we apply the
direction filter.
It has also been suggested [5] that the false positive rate
can be reduced by increasing the significance level in a
combined group analysis. The bottom row of Table 1
shows that a combined analysis using a significance level
of 10-4 achieves a significance level similar than the 3-
group strategy, and a greater power. But, of course, this is
not a fair comparison: If we apply this new significance
level with a 3-group strategy, we would obtain again a
reduction in the false positive rate.
A final comparison is reported in the last column of
Table 1. We simulated a mixed population, where one
replication group produces an association signal, while
two other replication samples are simulated under the
null hypothesis of no association. We found that the com-
bined group analysis detected the association 71 and 50
percent of the time, but the 3-group analysis did not
detect it even once. In addition, the false positive rate was
lowest for the 3-group analysis with direction filter.
Discussion
We have evaluated the power and Type I error rate of two
possible analysis strategies: a combined group analysis of
the full sample, and a replication group analysis. The
results presented in Table 1 and in the Results section
show that applying a replication group analysis with a
direction filter reduces the false positive rate relative to a
combined group analysis. It is important to note here that
the combined analysis is more powerful, something
Table 1: Power and Type I error rates for several simulated datasets and analysis strategies.
OR
Analysis Type 1.67 2.10 2.85 1.57 Mixed
Combined group (p = 10-3) Power 90 100 100 71
False positive rate 0.00379 0.01144 0.02448 0.00297
3 group No Direction (p = 10-1) Power 57 100 100 0
False positive rate 0.00197 0.00538 0.01713 0.00108
3 group Direction (p = 10-1) Power 57 100 100 0
False positive rate 0.00121 0.00486 0.01645 0.00039
Combined group (p = 10-4) Power 66 100 100 50
False positive rate 0.00103 0.00571 0.01824 0.00070
Each dataset consists of 3000 cases and 3000 controls genotyped for 20 SNPs, and each experimental dataset was simulated 100 times. The 
simulated effect size for each experiment (a pair of SNPs per simulation) had an average Odds-Ratio (OR) of 1.67, 2.10, and 2.85. A final mixed 
model (overall OR of 1.57) resulted from the combination of two null simulations with a simulation with a pair of SNPs associated with case-
status. The combined-group strategy analyzed the full sample size simultaneously (3000 cases and 3000 controls), and was applied for two 
different significance levels (p = 10-3 and p = 10-4). The 3-replication-group strategy analyzed three replication groups, each with 1000 cases 
and 1000 controls, with a significance level of p = 10-1 in each group. Results with and without applying a direction filter (consistency of results 
in size and direction of effect across replication groups) are shown. Power is expressed as a percentage.Gayán et al. BMC Genomics 2010, 11:403
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already mentioned in our original paper, and therefore is
preferable for selecting the top signals of a study. None-
theless, when lack of replicability of results is an issue,
using a multiple-group strategy is an useful tool to select
a large subset of results that are consistent across groups,
and that may replicate in future independent replication
studies.
As we stated in our original article [4], the replication
groups strategy is used to select a large subset of prelimi-
nary results, which are then subjected to post-hoc analy-
sis for prioritization. We used the replication groups to
eliminate the tail of false positive results, not to choose
the top best signals (scoring or ranking), which is done in
a post-hoc analysis. This is a key misinterpretation of our
strategy in the Toplak et al. article, and, although we will
not mention them all here, there are several others. For
example, they claim we did not compare in our original
publication a multiple-group strategy versus a combined
group strategy [[5], page 1], but we compared them and
stated that the analysis of the Parkinson Disease dataset,
in a single combined group, yielded 784,506 pairs of SNPs
at a p-value of 10-6. The same analysis, with 3 replication
groups each at p-value of 10-2, yielded only 418,535 pairs
[[4], page 12]. Moreover, when the direction filter was
applied to this 3-group strategy, then the analysis only
yielded 320,265 pairs [[4], Table 2], a significant decrease.
When the multiple group strategy is used, it is impor-
tant to use the direction filter, to select only those signals
significant in each group but also consistent in the direc-
tion of effect. Our original simulations suggested this fil-
ter may eliminate about 24% of the signals selected by the
3-group analysis [[4], pages 7-8]. It is not clear from their
article whether Toplak et al. have applied a direction fil-
ter. It seems they have selected signals above a statistical
threshold, but may have failed to select only those results
with the same direction of effect in all groups. If this is
true, then the results published in their article [5] are
compromised, because it seems straightforward that
selecting only consistent results, in both strength and
direction, will reduce the number of false positives
selected in the multiple-group analysis. Indeed, the
results presented in Table 1 and in the Results section
show that applying a replication group analysis with a
direction filter lowers the false positive rate relative to a
combined group analysis.
Toplak et al. also argue that instead of using multiple
replication groups, a decrease in false positives can be
achieved by simply raising the significance level in a com-
bined group analysis [[5], page 7], a statement with which
we obviously agree. However, if this new significance
level is applied with multiple replication groups, the false
positive rate would be lower again than for the combined
analysis.
We have also shown that when the replication groups
are heterogeneous, a combined group analysis may detect
the signal that is due to a subset of the sample, but a mul-
tiple-group analysis with direction filter protects against
this potential source of bias. Obviously, if there is hetero-
geneity across samples and the effect is real only in some
subsets, the combined analysis is more powerful to detect
a potentially true effect, even though the effect could be
erroneously generalised to all three groups. However, if
the goal is to find results consistent across replication
groups, and protect against false positive results, then the
replication-group strategy provides this added value.
We also want to note that our multiple group strategy
has its roots in the ability to analyze simultaneously mul-
tiple related phenotypes (such as comorbid or related dis-
eases). This is another advantage of HFCC, which is
inherently designed to allow this type of analysis. More-
over, some gene factors may have a risk effect on a dis-
ease, and a protective effect on another one, a possibility
that can only be addressed with multiple-groups and flex-
ible direction filters.
Conclusion
Replication of results in independent samples is generally
used in scientific studies to establish credibility in a find-
ing [8]. It protects against bias from unmeasured sources
of noise (stratification, sampling or selection bias, techni-
cal artefacts or non-random genotype errors, heterogene-
ity across samples). Replication across samples has
become the standard strategy in recent years with the
proliferation of genome-wide studies of many diseases.
Nonetheless, the combined analysis of several datasets is
k n o w n  t o  b e  a  p r e f e r a b l e  a n d  m o r e  p o w e r f u l  s t r a t e g y
[6,7] for the selection of top signals. HFCC [4] is a flexible
analysis tool, and one of its analysis options combines
these two strategies: A preliminary multiple replication
group analysis to eliminate inconsistent false positive
results, and a post-hoc combined-group analysis to select
the top signals. HFCC, however, is a more complete soft-
ware which includes other analysis options and method-
ologies. This article explains these concepts and shows
that using replication groups with direction of effect low-
ers the false positive rate.
As a summary of our results, if the goal of an analysis is
to select the best top signals, a combined group analysis
provides the most powerful approach. Subdividing a large
homogeneous sample into several smaller subsets is not
generally recommended in this case, unless there is some
evidence of heterogeneity. When there exist several inde-
pendent and heterogeneous samples, different in case
selection, geographical location, race, genotyping, etc., or
even sample size, applying a multiple replication group
strategy may help eliminate false positive signals andGayán et al. BMC Genomics 2010, 11:403
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select results consistent across groups. Genomewide
studies of large datasets are showing that, for reasons not
clear yet, but probably due to sampling, technical or
genotyping differences, the top signals are not consis-
tently replicating in independent samples (the winner's
curse). On the contrary, signals down the top rankings are
the ones finally replicating. Because in the recent history
of genetic studies of complex traits it has been hard to
find consistent results [8], and the level of noise to true
signals is large [10], a replication group strategy seems
useful for this sort of studies.
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